The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBTG Share News (BTG)

  • There is currently no data for BTG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: Rolls Royce Soars On Cash Flow Guidance

Fri, 15th Jun 2018 10:56

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - WINNERS----------Rolls Royce Holdings, up 11%. The jet engine maker laid out its target to exceed GBP1 per share of free cash flow generation and a cash flow return on invested capital of 15% in the medium term. In 2017, free cash flow generation stood at 15 pence, while return on invested capital was 9%. The company also said that it is well-placed to now exceed free cash flow of GBP1 billion by 2020. Power Systems, the company's engine manufacturing unit, is predicted to achieve revenue growth of 3 to 5 percentage points above underlying GDP and an operating profit margin in the mid-teens versus 11.3% in 2017. The London-headquartered company also said that it will incur additional GBP100 million cost relating to in-service issues with its Trent 1000 Package C and B engines, due increased level of inspection and intervention. It has implemented a number of short-term cost savings actions separate to the new restructuring plan announced on Thursday to offset the increased costs.----------Tesco, up 2.2% The retail chain said that for the 13-week period to May 26, the company posted 1.8% growth in group like-for-like sales compared to 1.0% growth recorded a year ago, on the back of a good performance in its core UK and Ireland business. The UK & Ireland business generated like-for-like sales growth of 3.5% versus 2.2% last year. In the UK, sales increased 2.1%, while in Ireland they were up 3.0%. Booker saw like-for-like sales, including tobacco, up 14.3%, driven by a strong underlying performance and new business wins, the company said. Tesco's international performance reported a downfall, with like-for-like sales in central Europe and Asia down 1% and 9%, respectively, as the increase in fresh food sales was offset by "specific market factors". The company said sales in central Europe were negatively affected by some regulatory changes. ----------Intercontinental Hotels Group, up 1.2%. JPMorgan raised the hotel operator to a Neutral rating from Underperform, and increased the price target to 4,350 pence from 3,680p.----------FTSE 100 - LOSERS----------BHP Billiton, down 1.9%. On Thursday, the Anglo-Austrailian mining company said it is to spend USD2.9 billion on the South Flank iron mine project in the central Pilbara region of Western Australia. BHP said South Flank will "fully" replace production from the nearby Yandi mine, which is reaching the end of its economic life. The Anglo-Australian miner is to build an 80 million tonne of ore per year crushing and screening plant at South Flank, as well as a conveyor system, stockyard and train loading facilities, and also buy a new mining fleet and undertake "substantial" mine development work. BHP is hoping to have first ore from South Flank during 2021, and its life-of-mine is expected to be over 25 years. In addition, BHP signed a contract with Hoctief AG's Australian subsidiary CIMIC Group Ltd for the latter to provide bulk earthworks construction, concrete and construction services for the project.----------FTSE 250 - WINNERS----------Synthomer, up 2.7%. Deutsche Bank raised the polymer supplier's price target to 630 pence from 565p, retaining its Buy rating.----------FTSE 250 - LOSERS----------Indivior, down 17%. The US Food & Drug Administration approved the first generic versions of Suboxone sublingual film for the treatment of opioid dependence. In April Indivior, the opioid-addiction treatment producer, had filed lawsuits against several companies for the infringement of US patent 9,931,305 relating to their versions of the Indivior's Suboxone Sublingual Film product. The lawsuits alleged that the companies Dr Reddy's, Actavis, Par, Alvogen and Teva infringe the patent, which claims film compositions that have a substantial uniform distribution of active drug. Now Mylan Technologies Inc and Dr Reddy's have received approval to market buprenorphine and naloxone sublingual film in multiple strengths. Buprenorphine and naloxone sublingual film should be used as part of a complete treatment plan that includes counseling and psychosocial support.----------AVEVA Group, down 5.2%. Barclays cut the electrical and industrial software provider to an Equal Weight rating from Overweight.----------Stobart Group, down 4.0%. The logistics firm, following the firing of former Chief Executive Andrew Tinkler and the start of legal proceedings against him on Thursday, said it would change its structure from a collection of business into a more tightly focused group for Aviation and Energy, and encouraged shareholders to re-elect Iain Ferguson as director and chairman.----------BTG, down 4.0%. The healthcare company said that the Anesthesiology & Respiratory Therapy Devices Panel of the Medical Devices Advisory Committee of the US Food & Drug Administration has voted against recommending approving BTG's Elevair emphysema treatment. The panel voted against the claim that Elevair is "effective for use in patients" and also against the claim that "the benefits of Elevair outweigh the risks". Elevair, marketed as PneumRx Coils in the EU, is a type of coil that is implanted into the lungs of emphysema patients in order to hold open their airways when they exhale. This treatment is intended to prevent the airways from collapsing. The panel's recommendation against the treatment is non-binding but will be considered by the FDA as part of its ongoing review of Elevair. The review is expected to conclude "in late summer 2018", the company said.----------OTHER MAIN MARKET AND AIM - WINNERS----------China Nonferrous Gold, up 13%. The mining company said its subsidiary Kryso Resources Ltd has entered a supplementary consultancy contract with China 15th Construction Group Co Ltd for the construction of tailing ponds on the Pakrut Gold Project in Tajikistan.----------Velocity Resources, up 12%. The aircraft-focused carbon fibre manufacturer acquired an award to supply composite material kits to a manufacturer of component parts for the Leading Edge Aviation Propulsion engines. The contract is expected to run until December 2020, and contribute up to USD6 million to Velocity's revenue over the period. ----------OTHER MAIN MARKET AND AIM - LOSERS----------Orosur Mining, down 38%. The South America-focused gold producer's subsidiary Loryser SA has applied to start reorganisation proceedings under Uruguayan legislation. This is due to operational challenges at the San Gregorio Underground Mine, and the lack of alternative ore sources leading to financial liquidity constraints. As a result, Orosur is planning to transition from San Gregorio to the Veta A underground project, however this will require external funds and the environmental permit in Veta A, which is not currently available.----------KEFI Minerals, down 25%. The gold mining company said it intends to raise GBP5.5 million through a placing of 120 million shares, and a subscription issue of up to 100 million shares, all at a price of 2.5 pence per share. Proceeds will go towards enabling the closing of the USD260 million project financing of the Tulu Kapi Gold Project in Ethiopia. The project is now solely dependent on government approval and due diligence to start.----------UK Oil & Gas Investments, down 21%. The natural resources investment company raised GBP5.5 million through a placing of 611.1 million shares at a price of 0.9 pence each. Proceeds will go towards funding its portion of the Horse Hill-2 appraisal well in Sussex, lease two wells sites in PEDL234 and one well site for the Arrenton oil discovery, and funding UK Oil & Gas' share of the planned Portland and Kimmeridge Holmwood well which is estimated to contain 920,000 barrels in prospective resources.----------
More News
4 Oct 2018 08:29

BTG Upgrades Annual Targets After Strong Interims, Chairman Retires

LONDON (Alliance News) - Healthcare company BTG PLC on Thursday upped its guidance for its current financial year as well as announced the retirement of Chairman Garry Watts.BTG said it has

Read more
4 Oct 2018 07:36

BTG upgrades sales forecasts on back of strong oncology, vascular portfolio

(Sharecast News) - Healthcare company BTG said it had delivered good first half sales growth, driven by the performance of its interventional medicine business as it upgraded its full year sales growth forecast in its oncology and vascular portfolio to 15-17%.

Read more
25 Sep 2018 12:57

Tuesday broker round-up

(Sharecast News) - Wetherspoons: Peel Hunt downgrades to hold with a target price of 1,325p.

Read more
17 Sep 2018 15:10

Monday broker round-up

(Sharecast News) - Sophos: Deutsche Bank downgrades to hold with a target price of 530p.

Read more
7 Sep 2018 07:53

BTG Buys Medical Device Outfit Novate Medical For Up To USD20 Million

LONDON (Alliance News) - FTSE 250-listed healthcare group BTG PLC said on Monday it has acquired medical device company Novate Medical Ltd for USD20 million in cash.BTG said it may be to of

Read more
7 Sep 2018 07:04

BTG to buy Novate for up to $130m

(Sharecast News) - Healthcare company BTG on Friday said it was paying up to $130m in cash to buy Ireland-based Novate, which specialises in the prevention of pulmonary embolism (PE) in patients at high risk of venous thromboembolic events.

Read more
9 Aug 2018 09:04

BTG's emphysema treatment struck down by FDA

(Sharecast News) - Global specialist healthcare company BTG on Thursday received confirmation from the US food and drug administration (FDA) that its emphysema treatment will not receive pre-market approval.

Read more
9 Aug 2018 09:04

BTG's emphysema treatment struck down by FDA

(Sharecast News) - Global specialist healthcare company BTG on Thursday received confirmation from the US food and drug administration (FDA) that its emphysema treatment will not receive pre-market approval.

Read more
9 Aug 2018 08:44

LONDON MARKET OPEN: Stocks Down As TUI, Randgold And Evraz Disapppoint

LONDON (Alliance News) - Stock prices in London were lower on Thursday, despite having been pointed to a higher open, with company results dragging down both the FTSE 100 and FTSE 250 indices, while

Read more
23 Jul 2018 16:08

DIRECTOR DEALINGS: BTG Non-Exec Director Buys Shares For GBP74,850

LONDON (Alliance News) - BTG PLC said Monday that Non-Executive Director Anne Thorburn bought 15,000 shares in the healthcare company.Thorburn acquired the shares at 499.81 pence each in a

Read more
15 Jun 2018 08:52

LONDON MARKET OPEN: FTSE Flat As China Promises To Retaliate On Trade

LONDON (Alliance News) - Stocks in London saw a cautious start to trading on Friday amid renewed trade war fears souring investor sentiment, as Rolls-Royce led the blue chips after sticking to its to

Read more
15 Jun 2018 08:15

TOP NEWS: BTG Fails To Gain FDA Panel Support For Emphysema Treatment

LONDON (Alliance News) - BTG PLC said Friday that the Anesthesiology & Respiratory Therapy Devices Panel of the Medical Devices Advisory Committee of the US Food & Drug Administration has

Read more
15 Jun 2018 07:37

LONDON MARKET PRE-OPEN: Tesco Has Strong Quarter; BTG Suffers Setback

LONDON (Alliance News) - Stock prices in London are seen opening marginally higher on Friday amid weakness in the pound, as Tesco delivered a strong first-quarter performance buoyed

Read more
18 May 2018 17:06

LONDON MARKET CLOSE: FTSE 100 Posts Eighth Weekly Gain; Glencore Slips

LONDON (Alliance News) - Despite a pullback on Friday preventing the FTSE 100 posting a new all-time high, the index nonetheless managed to end higher for its eighth consecutive week.Ending lower on

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.